Making medicines has never been easy. But in today's global health care environment, the challenges are unprecedented. Familiar ways of working aren't working anymore, so Lilly is transforming to meet the challenges head on — from how we make medicines to how we talk about them. Throughout our organization, we’re asking tough questions and discovering better answers.
October 15, 2008: Shanghai, China.
Eli Lilly and Company announced today that it has officially opened a research and development headquarters in China. The Shanghai office will house a scientific management and venture investment team, with a mission to identify, foster and manage collaboration opportunities with local firms and academic institutions.
